- Home
- AVT vs ADMA Comparison
AVT vs ADMA Comparison
Compare AVT & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVT
- ADMA
- Stock Information
- Founded
- AVT 1921
- ADMA 2004
- Country
- AVT United States
- ADMA United States
- Employees
- AVT N/A
- ADMA N/A
- Industry
- AVT Electronic Components
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AVT Technology
- ADMA Health Care
- Exchange
- AVT Nasdaq
- ADMA Nasdaq
- Market Cap
- AVT 4.3B
- ADMA 5.1B
- IPO Year
- AVT N/A
- ADMA N/A
- Fundamental
- Price
- AVT $53.64
- ADMA $16.16
- Analyst Decision
- AVT Sell
- ADMA Strong Buy
- Analyst Count
- AVT 3
- ADMA 3
- Target Price
- AVT $49.00
- ADMA $27.67
- AVG Volume (30 Days)
- AVT 1.1M
- ADMA 3.1M
- Earning Date
- AVT 10-29-2025
- ADMA 11-06-2025
- Dividend Yield
- AVT 2.46%
- ADMA N/A
- EPS Growth
- AVT N/A
- ADMA 469.09
- EPS
- AVT 2.75
- ADMA 0.85
- Revenue
- AVT $22,200,754,000.00
- ADMA $474,174,000.00
- Revenue This Year
- AVT $5.51
- ADMA $21.08
- Revenue Next Year
- AVT $6.01
- ADMA $25.98
- P/E Ratio
- AVT $19.51
- ADMA $19.02
- Revenue Growth
- AVT N/A
- ADMA 43.58
- 52 Week Low
- AVT $39.22
- ADMA $13.50
- 52 Week High
- AVT $59.24
- ADMA $25.67
- Technical
- Relative Strength Index (RSI)
- AVT 50.63
- ADMA 44.07
- Support Level
- AVT $51.90
- ADMA $15.14
- Resistance Level
- AVT $54.15
- ADMA $17.17
- Average True Range (ATR)
- AVT 1.04
- ADMA 0.57
- MACD
- AVT -0.07
- ADMA -0.05
- Stochastic Oscillator
- AVT 56.51
- ADMA 44.93
About AVT Avnet Inc.
Avnet Inc is a global distributor of electronic components, connecting suppliers of semiconductors and other components to a base of 2.1 million small- and mid-sized customers in 140 countries. Avnet is the third largest semiconductor distributor in the world, and the largest for European chip distribution. Avnet services all levels of electronics design and development, servicing engineers with design tools, test kits, and services alongside its high-volume distribution for final designs.
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.